OPTN (OptiNose, Inc.) קצב צמיחת רווח למניה בשנה הנוכחית
OptiNose, Inc. (OPTN) possesses a unique nasal drug delivery technology that has earned recognition from industry specialists. The annual EPS growth rate reflects profit dynamics, with the value holding at 52.10. This trend is supported by stable working capital sufficient to cover all liabilities. Supply stability is guaranteed through the complete outsourcing of production to certified plants in Europe and the US.
פילוחי מדדים מקיפים ואנליטיקה עבור OptiNose, Inc. (OPTN)
The efficiency of implementing drug delivery systems into the nasal sinuses through partnerships with otolaryngologists directly impacts the net profit dynamics of OptiNose, Inc. (OPTN). This metric calculates the percentage deviation of the current earnings per share from the same period last year, measuring the pace of business scaling. Analyzing annual EPS fluctuations allows for an assessment of demand stability for innovative sinusitis treatments and helps avoid overpaying for the asset.
